Atai Life Sciences Current Ratio 2020-2023 | ATAI
Atai Life Sciences current ratio from 2020 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Atai Life Sciences Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2023-12-31 | $0.19B | $0.02B | 9.22 |
| 2023-09-30 | $0.22B | $0.02B | 10.96 |
| 2023-06-30 | $0.24B | $0.02B | 13.54 |
| 2023-03-31 | $0.27B | $0.02B | 13.43 |
| 2022-12-31 | $0.29B | $0.02B | 14.43 |
| 2022-09-30 | $0.32B | $0.03B | 12.25 |
| 2022-06-30 | $0.32B | $0.02B | 14.74 |
| 2022-03-31 | $0.35B | $0.02B | 15.79 |
| 2021-12-31 | $0.38B | $0.02B | 17.92 |
| 2021-09-30 | $0.44B | $0.02B | 28.85 |
| 2021-06-30 | $0.46B | $0.01B | 32.26 |
| 2021-03-31 | $0.13B | $0.02B | 6.88 |
| 2020-12-31 | $0.10B | $0.01B | 8.10 |
| 2020-09-30 | $0.00B | 0.00 | |
| 2020-06-30 | $0.00B | 0.00 | |
| 2020-03-31 | $0.00B | 0.00 | |
| 2019-12-31 | $0.04B | $0.00B | 24.36 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.323B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $16.392B | 9.92 |
| Quest Diagnostics (DGX) | United States | $14.915B | 15.41 |
| DaVita (DVA) | United States | $11.709B | 15.93 |
| Chemed (CHE) | United States | $8.472B | 26.30 |
| Encompass Health (EHC) | United States | $8.259B | 21.25 |
| Elanco Animal Health (ELAN) | United States | $6.552B | 14.90 |
| Option Care Health (OPCH) | United States | $5.147B | 19.48 |
| RadNet (RDNT) | United States | $3.314B | 96.80 |
| Amedisys (AMED) | United States | $2.999B | 21.25 |
| LifeStance Health (LFST) | United States | $2.370B | 0.00 |
| Astrana Health (ASTH) | United States | $2.057B | 25.68 |
| Addus HomeCare (ADUS) | United States | $1.548B | 23.52 |
| U.S Physical Therapy (USPH) | United States | $1.516B | 39.30 |
| Pennant (PNTG) | United States | $0.624B | 36.46 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.423B | 0.00 |
| Daxor (DXR) | United States | $0.046B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.029B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.018B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.014B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.005B | 0.00 |